EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Supramonomer‐Based Glyco‐Cationic Nanoparticles With GSH Depletion‐Enhanced Drug/Gene Co‐Delivery for Combination Therapy

Yuchao Lu, Tian Shi, Wanqiang Liu, Danhong Shang, Xinping Liu, Qiang Wang, Xue Yang, Xinyue Ge, Yanjie Jia, Pengkun He, Kai Zhang, Changping Hu und 2 weitere

Medicine Bulletin · 2025

DOI: 10.1002/mdb2.70015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine Bulletin, 2025. Verfasst von Yuchao Lu und 13 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To address chemotherapy limitations including systemic toxicity and multidrug resistance (MDR), we engineered degradable supramolecular polymer nanoparticles (Gla‐H6⊃D‐SS‐Fc NPs) based on supramolecular monomer (Gla‐H6⊃D‐SS‐Fc). This supramolecular monomer was constructed through host–guest interactions between galactose‐functionalized pillar[6]arene (Gla‐H6, host) and dopamine‐derived ferrocene‐cystamine (D‐SS‐Fc, guest), followed by oxidative self‐polymerization of dopamine groups to form stable nanoparticles (∼130 nm). The supramolecular polymer nanoparticles exhibited high doxorubicin (DOX) loading efficiency (50.5%) and pH/GSH‐triggered release kinetics. In vitro studies confirmed receptor‐mediated cellular uptake in HepG‐2 cells, enhanced tumor specificity, and low cytotoxicity toward normal hepatocytes (HL7702). Co‐delivery of DOX and siRNA synergistically suppressed P‐glycoprotein expression, reversing MDR in HepG‐2‐ADR cells. This supramolecular monomer‐based degradable polymer platform integrates tumor targeting, GSH/pH dual‐responsiveness, and combinatorial therapy, demonstrating significant clinical potential against chemoresistant tumors.

Zitieren

APA

Lu, Y., Shi, T., Liu, W., Shang, D., Liu, X., Wang, Q., Yang, X., Ge, X., Jia, Y., He, P., Zhang, K., Hu, C., Chen, L., & Duan, X. (2025). Supramonomer‐Based Glyco‐Cationic Nanoparticles With GSH Depletion‐Enhanced Drug/Gene Co‐Delivery for Combination Therapy. Medicine Bulletin. https://doi.org/10.1002/mdb2.70015

Vancouver

Lu Y, Shi T, Liu W, Shang D, Liu X, Wang Q, et al. Supramonomer‐Based Glyco‐Cationic Nanoparticles With GSH Depletion‐Enhanced Drug/Gene Co‐Delivery for Combination Therapy. Medicine Bulletin. 2025. doi:10.1002/mdb2.70015

BibTeX
@article{Lu2025,
  author = {Lu, Yuchao and Shi, Tian and Liu, Wanqiang and Shang, Danhong and Liu, Xinping and Wang, Qiang and Yang, Xue and Ge, Xinyue and Jia, Yanjie and He, Pengkun and Zhang, Kai and Hu, Changping and Chen, Lan and Duan, Xiao},
  title = {Supramonomer‐Based Glyco‐Cationic Nanoparticles With GSH Depletion‐Enhanced Drug/Gene Co‐Delivery for Combination Therapy},
  journal = {Medicine Bulletin},
  year = {2025},
  doi = {10.1002/mdb2.70015}
}
Kostenlos starten →